Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
JABBOUR, ELIAS JOSEPH
One or more keywords matched the following items that are connected to JABBOUR, ELIAS JOSEPH
Item TypeName
Concept Sialic Acid Binding Ig-like Lectin 2
Academic Article Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study.
Academic Article Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia.
Academic Article Inotuzumab ozogamicin in B-cell acute lymphoblastic leukemias and non-Hodgkin's lymphomas.
Academic Article Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemia.
Academic Article A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia.
Academic Article Treatment of adult acute lymphoblastic leukemia with inotuzumab ozogamicin.
Academic Article Patient-reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia.
Academic Article Progress and Innovations in the Management of Adult Acute Lymphoblastic Leukemia.
Concept Sialic Acid Binding Ig-like Lectin 3
Academic Article Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
Academic Article Therapy Options in Treating Acute Lymphoblastic Leukemia in Adults.
Academic Article Inotuzumab Ozogamicin for Relapsed/Refractory Acute Lymphoblastic Leukemia in the INO-VATE Trial: CD22 Pharmacodynamics, Efficacy, and Safety by Baseline CD22.
Search Criteria
  • N Acetylneuraminic Acid